Literature DB >> 32301427

Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum.

Clodoveo Ferri1, Dilia Giuggioli2, Serena Guiducci3, Federica Lumetti2, Gianluigi Bajocchi4, Luca Magnani4, Veronica Codullo5, Alarico Ariani6, Francesco Girelli7, Valeria Riccieri8, Greta Pellegrino8, Silvia Bosello9, Rosario Foti10, Elisa Visalli10, Giorgio Amato10, Alessia Benenati10, Giovanna Cuomo11, Florenzo Iannone12, Fabio Cacciapaglia12, Rossella De Angelis13, Francesca Ingegnoli14, Rossella Talotta15, Corrado Campochiaro16, Lorenzo Dagna16, Giacomo De Luca16, Silvia Bellando-Randone17, Amelia Spinella2, Giuseppe Murdaca18, Nicoletta Romeo19, Maria De Santis20, Elena Generali20, Simone Barsotti21, Alessandra Della Rossa21, Ilaria Cavazzana22, Francesca Dall'Ara23, Maria G Lazzaroni24, Franco Cozzi25, Andrea Doria25, Erika Pigatto25, Elisabetta Zanatta25, Giovanni Ciano26, Lorenzo Beretta27, Giuseppina Abignano28, Salvatore D'Angelo28, Gianna Mennillo28, Gianluca Bagnato29, Francesca Calabrese30, Maurizio Caminiti30, Giuseppa Pagano Mariano30, Elisabetta Battaglia31, Ennio Lubrano32, Giovanni Zanframundo5, Annamaria Iuliano33, Federica Furini34, Anna Zanetti35, Greta Carrara35, Federica Rumi35, Carlo Alberto Scirè36, Marco Matucci-Cerinic3.   

Abstract

OBJECTIVES: Systemic sclerosis (SSc) is a severe multiple-organ disease characterised by unpredictable clinical course, inadequate response to treatment, and poor prognosis. National SSc registries may provide large and representative patients cohorts required for descriptive and prognostic studies. Therefore, the Italian Society of Rheumatology promoted the registry SPRING (Systemic sclerosis Progression INvestiGation).
METHODS: The SPRING is a multi-centre rheumatological cohort study encompassing the wide scleroderma spectrum, namely the primary Raynaud's phenomenon (pRP), suspected secondary RP, Very Early Diagnosis of Systemic Sclerosis (VEDOSS), and definite SSc. Here we describe the demographic and clinical characteristics of a population of 2,028 Italian patients at the initial phase of enrollment, mainly focusing on the cohort of 1,538 patients with definite SSc.
RESULTS: Definite SSc showed significantly higher prevalence of digital ulcers, capillaroscopic 'late' pattern, oesophageal and cardio-pulmonary involvement compared to VEDOSS, as expected on the basis of the followed classification criteria. The in-depth analysis of definite SSc revealed that male gender, diffuse cutaneous subset, and anti-Scl70 seropositivity were significantly associated with increased prevalence of the most harmful disease manifestations. Similarly, patients with very short RP duration (≤1 year) at SSc diagnosis showed a statistically increased prevalence of unfavourable clinico-serological features.
CONCLUSIONS: Nationwide registries with suitable subsetting of patients and follow-up studies since the prodromal phase of the disease may give us valuable insights on the SSc natural history and main prognostic factors.

Entities:  

Year:  2020        PMID: 32301427

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

1.  Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center.

Authors:  Amelia Spinella; Luca Magnani; Marco De Pinto; Chiara Marvisi; Luca Parenti; Gianluigi Bajocchi; Carlo Salvarani; Maria Teresa Mascia; Dilia Giuggioli
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2021-03-17

Review 2.  Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.

Authors:  Changyi Yang; Shunli Tang; Dingxian Zhu; Yingguo Ding; Jianjun Qiao
Journal:  Front Med (Lausanne)       Date:  2020-11-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.